ADVANCED MALIGNANCIES
Clinical trials for ADVANCED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCIES trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug BR111 enters first human tests
Disease control Recruiting nowThis early-stage study tests a new drug, BR111, in about 166 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to find the safest dose and to see how the drug behaves in the body. Researchers will also watch for any anti-tumor ac…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with pembrolizumab, in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard therapy. The main goals are to check safety, find the best dose, and see if…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
New cancer drug BRY812 enters first human trials
Disease control Recruiting nowThis early-stage study tests a new drug, BRY812, in people with advanced solid tumors that no longer respond to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it can shrink tumors. Participants receive the drug every three weeks…
Matched conditions: ADVANCED MALIGNANCIES
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:57 UTC